Clinical Trial Update: An Open, Single-center, Safety and Efficacy Study of Conbercept in Patients With Very Low Vision Secondary to Wet Age-related Macular Degeneration (wAMD) [Phase 2]

View source ↗

Summary

This open, single-center Phase 2 trial evaluates the safety and efficacy of Conbercept in patients with very low vision due to wet age-related macular degenerat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Wet Age-related Macular Degeneration

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Very Low Vision Secondary to Wet Age-related Macular Degeneration | Phase 2 | Status: UNKNOWN